We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright

News   Aug 04, 2009

 
454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright
 
 
 

RELATED ARTICLES

Green Tea Acts as a "Remote Control" To Switch on Cell Therapy

News

In a new study published today in Science Advances, researchers from East China Normal University have created an elegant system for activating genetically edited cells using green tea.

READ MORE

Novel Neurological Syndrome Common in Countries Where Consanguineous Marriage is Prevalent

News

Scientists may have discovered a new neurological syndrome that seems to be most common in countries with high prevalence of marriage between genetically-related individuals.

READ MORE

RNA Folding Insights Lead to New Therapeutics and Synthetic Biology Technologies

News

A research team has uncovered a new understanding of how RNA molecules act as cellular "biosensors" to monitor and respond to changes in the environment by controlling gene expression.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE